TABLE 1 GLOBAL NANOMEDICINE MARKET REVENUE BY APPLICATION TYPE' 2017-2023 ($BILLION) 32
TABLE 2 IOE HEALTHCARE MARKET REVENUE BY TYPE' 2016-2022 ($BILLION) 36
TABLE 3 TECHNOLOGIES MARKET REVENUE BY TYPE' 2016-2022 ($BILLION) 37
TABLE 4 NETWORK TECHNOLOGIES MARKET REVENUE BY RANGE' 2016-2022 ($BILLION) 38
TABLE 5 SHORT RANGE NETWORK TECHNOLOGIES MARKET REVENUE' 2016-2022 ($BILLION) 38
TABLE 6 IOT HEALTHCARE MARKET REVENUE BY SERVICES' 2016-2022 ($BILLION) 42
TABLE 7 TELEMEDICINE MARKET REVENUE BY TYPE' 2016-2022 ($BILLION) 43
TABLE 8 MERCK & CO. INC.: RECENT DEVELOPMENTS 53
TABLE 9 HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 58
TABLE 10 GILEAD SCIENCES: KEY MEDICINES/PRODUCTS 62
TABLE 11 GILEAD SCIENCES: PIPELINE PRODUCTS 63
TABLE 12 GILEAD SCIENCES: RECENT DEVELOPMENTS 65
TABLE 13 NOVARTIS AG: RECENT DEVELOPMENTS 69
TABLE 14 AMGEN INC.: RECENT DEVELOPMENTS 74
TABLE 15 PFIZER INC.: RECENT DEVELOPMENTS 77
TABLE 16 ELI LILLY AND COMPANY: RECENT DEVELOPMENTS 79
TABLE 17 MERGER & ACQUISITION' 2014-2015 85
LIST OF FIGURE
CHART 1 PEST ANALYSIS OF NANOMEDICINE MARKET 12
CHART 2 RESEARCH METHODOLOGY OF GLOBAL NANOMEDICINE MARKET 14
CHART 3 GLOBAL NANOMEDICINE MARKET REVENUE' 2016-2023 ($BILLION) 16
CHART 4 SHARE OF ENROLLMENT BY VARIOUS INSURANCE PROGRAMS 18
CHART 5 PORTERS 5 FORCES ON IOT HEALTHCARE MARKET 19
CHART 6 EVOLUTION OF NANOMEDICINES 20
CHART 7 ECOSYSTEM OF IOT HEALTHCARE MARKET 23
CHART 8 IOT HEALTHCARE MARKET SEGMENTATION 24
CHART 9 MARKET DYNAMICS - DRIVERS' RESTRAINTS & OPPORTUNITIES 25
CHART 10 DRO - IMPACT ANALYSIS OF IOT HEALTHCARE MARKET 29
CHART 11 TECHNOLOGY ROADMAP FOR IOT HEALTHCARE MARKET 31
CHART 12 NANOMEDICINE MARKET BY THERAPEUTIC APPLICATIONS 32
CHART 13 GLOBAL NANOMEDICINE MARKET SHARE BY THERAPEUTIC APPLICATIONS 2016 32
CHART 14 GLOBAL NANOMEDICINE MARKET REVENUE IN ONCOLOGY SEGMENT' 2016-2023 ($BILLION) 33
CHART 15 GLOBAL NANOMEDICINE MARKET REVENUE IN CARDIOVASCULAR SEGMENT' 2016-2023 ($BILLION) 34
CHART 16 GLOBAL NANOMEDICINE MARKET REVENUE IN NEUROLOGY SEGMENT' 2016-2023 ($BILLION) 34
CHART 17 GLOBAL NANOMEDICINE MARKET REVENUE IN ANTI-INFLAMMATORY SEGMENT' 2016-2023 ($BILLION) 35
CHART 18 GLOBAL NANOMEDICINE MARKET REVENUE IN ANTI-INFECTIVE SEGMENT' 2016-2023 ($BILLION) 35
CHART 19 GLOBAL NANOMEDICINE MARKET REVENUE IN OTHER THERAPEUTIC SEGMENTS' 2016-2023 ($BILLION) 36
CHART 20 IOT HEALTHCARE MARKET REVENUE BY TECHNOLOGIES' 2016-2022 38
CHART 21 SHORT RANGE NETWORK MARKET REVENUE' 2015-2022 ($BILLION) 40
CHART 22 GEOGRAPHIC REVENUE IN 2016 (%) 46
CHART 23 MERCK & CO. INC.: OVERVIEW SNAPSHOT 51
CHART 24 MERCK & CO. INC.: BUSINESS UNITS 52
CHART 25 GE: GEOGRAPHIC REVENUE 53
CHART 26 MERCK & CO. INC.: SWOT ANALYSIS 55
CHART 27 HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 57
CHART 28 HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 58
CHART 29 HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 59
CHART 30 HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 61
CHART 31 GILEAD SCIENCES: OVERVIEW SNAPSHOT 63
CHART 32 GILEAD SCIENCES: BUSINESS UNITS 64
CHART 33 GILEAD SCIENCES: GEOGRAPHIC REVENUE 66
CHART 34 GILEAD SCIENCES: SWOT ANALYSIS 67
CHART 35 NOVARTIS AG: OVERVIEW SNAPSHOT 68
CHART 36 NOVARTIS AG: BUSINESS UNITS 68
CHART 37 NOVARTIS AG: GEOGRAPHIC REVENUE 70
CHART 38 NOVARTIS AG: SWOT ANALYSIS 72
CHART 39 AMGEN INC.: OVERVIEW SNAPSHOT 73
CHART 40 AMGEN INC.: BUSINESS UNITS 73
CHART 41 AMGEN INC.: GEOGRAPHIC REVENUE 75
CHART 42 AMGEN INC.: SWOT ANALYSIS 76